These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12176484)

  • 1. Mycophenolate's influence in the treatment of recurrent hepatitis c following liver transplantation.
    Smallwood GA; Davis L; Martinez E; Stieber AC; Heffron TG
    Transplant Proc; 2002 Aug; 34(5):1559-60. PubMed ID: 12176484
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
    Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1468-9. PubMed ID: 9636596
    [No Abstract]   [Full Text] [Related]  

  • 3. Grafts and hepatitis C virus: maximizing the benefit.
    Mottershead M; Neuberger J
    Liver Transpl; 2007 Jul; 13(7):947-52. PubMed ID: 17600347
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.
    Selzner N; Renner EL; Selzner M; Adeyi O; Kashfi A; Therapondos G; Girgrah N; Herath C; Levy GA; Lilly L
    Transplantation; 2009 Nov; 88(10):1214-21. PubMed ID: 19935376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
    Platz KP; Mueller AR; Willimski C; Mansoorian B; Berg T; Neuhaus R; Hopf U; Radke C; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2232-3. PubMed ID: 9723453
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
    Bahra M; Neumann UP; Harren M; Jacob D; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
    Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study comparing safety and efficacy of mycophenolate mofetil versus azathioprine in primary liver transplant recipients.
    Fischer L; Sterneck M; Gahlemann CG; Malago M; Rogiers X; Broelsch CE
    Transplant Proc; 2000 Nov; 32(7):2125-7. PubMed ID: 11120098
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C.
    Jain A; Kashyap R; Demetris AJ; Eghstesad B; Pokharna R; Fung JJ
    Liver Transpl; 2002 Jan; 8(1):40-6. PubMed ID: 11799484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil.
    Fasola CG; Netto GJ; Jennings LW; Christensen LL; Molmenti EP; Sanchez EQ; Levy MF; Goldstein RM; Klintmalm GB
    Transplant Proc; 2002 Aug; 34(5):1563-4. PubMed ID: 12176486
    [No Abstract]   [Full Text] [Related]  

  • 10. A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C.
    Rayhill SC; Barbeito R; Katz D; Voigt M; Labrecque D; Kirby P; Miller R; Stolpen A; Wu Y; Schmidt W
    Transplant Proc; 2006 Dec; 38(10):3625-8. PubMed ID: 17175350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L; Mazzoni A; Colombatto P; Bindi L; Biancofiore G; Tascini C; Menichetti F; Brunetto MR; Scatena F; Filipponi F
    Transplantation; 2008 Dec; 86(12):1666-71. PubMed ID: 19104402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term antiviral treatment for recurrent hepatitis C after liver transplantation.
    Bertuzzo VR; Cescon M; Morelli MC; Di Gioia P; Tamè M; Lorenzini S; Andreone P; Ercolani G; Del Gaudio M; Ravaioli M; Cucchetti A; Dazzi A; D'Errico-Grigioni A; Pinna AD
    Dig Liver Dis; 2012 Oct; 44(10):861-7. PubMed ID: 22819767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil as primary and rescue therapy in intestinal transplantation.
    Tzakis AG; Weppler D; Khan MF; Koutouby R; Romero R; Viciana AL; Raskin J; Nery JR; Thompson J
    Transplant Proc; 1998 Sep; 30(6):2677-9. PubMed ID: 9745545
    [No Abstract]   [Full Text] [Related]  

  • 14. Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction.
    Fasola CG; Netto GJ; Christensen LL; Molmenti EP; Sanchez EQ; Levy MF; Goldstein RM; Klintmalm GB
    Transplant Proc; 2002 Aug; 34(5):1561-2. PubMed ID: 12176485
    [No Abstract]   [Full Text] [Related]  

  • 15. Causes of graft loss following liver transplantation for chronic hepatitis C.
    O'Reilly PM; Rosen HR; Shackleton CR; McDiarmid S; Holt C; Busuttil RW; Martin P
    Transplant Proc; 1997; 29(1-2):526-8. PubMed ID: 9123116
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
    Berenguer M; Aguilera V; San Juan F; Benlloch S; Rubin A; López-Andujar R; Moya A; Pareja E; Montalva E; Yago M; de Juan M; Mir J; Prieto M
    Transplantation; 2010 Dec; 90(11):1204-9. PubMed ID: 21068701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha.
    Fischer L; Sterneck M; Valentin-Gamazo C; Feucht HH; Malagó M; Broelsch CE
    Transplant Proc; 1999; 31(1-2):494-5. PubMed ID: 10083207
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire?
    Charlton MR
    Liver Transpl; 2002 Jan; 8(1):47-9. PubMed ID: 11799485
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment: liver transplantation.
    McGuire BM; Alkurdi B
    Curr Opin Organ Transplant; 2009 Jun; 14(3):219-20. PubMed ID: 19455031
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
    Lengyel G; Tulassay Z
    Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.